Tesamorelin 10mg

Description

Tesamorelin 10mg, with the record needed for a careful review

Purity Collective supplies Tesamorelin 10mg in a lyophilized vial for qualified laboratory research. This page aligns the catalog identity, stated quantity, SKU and available analytical documents so procurement teams can evaluate the listing from the source records instead of relying on a short product claim.

If a procurement request calls for a different stated quantity, review the separate Tesamorelin 20mg listing as its own catalog record. Do not assume that documents or specifications from this 10mg listing apply to another variant.

Analytical results should be reviewed in context. Confirm the compound and lot identifiers, reported methods, dates, specifications and results across the full documents before making an internal acceptance decision.

Product details

Available analytical documents

Review the Tesamorelin 10mg UPLC/MS report and the Tesamorelin endotoxin report in full. The guide to reading a peptide COA provides a practical framework for comparing identity, lot, method, date, specification and result fields. For identity, FDA product-status boundaries and quantity-specific record review, read the Tesamorelin research and COA guide.

The UPLC/MS report identifies Tesamorelin and lists lot PCCL-4867057-P. For that submitted sample, it records a measured quantity of 10.13mg against a 10mg specification and a purity result of 99.23% against a greater-than-98% specification. Those figures are lot-specific report data, not universal guarantees for every unit.

The endotoxin report identifies lot PCCL-4867057-E and records a result below 0.05 EU/mL. It does not print an acceptance specification. Both reports display an analysis date of May 4, 2026 and a received date of May 9, 2026, so the analysis date appears earlier than the received date. That chronology should be considered during document review. Neither report establishes sterility, safety, suitability or performance.

Why Purity Collective presents the full record

A useful laboratory listing should make verification straightforward. Purity Collective pairs the stated identity and supplied format with direct access to the available documents, while separating report-specific measurements from general catalog facts. This gives qualified buyers a clearer basis for supplier qualification and their own acceptance process.

Before you order

• Confirm that Tesamorelin, the 10mg listed quantity and SKU PC-TESAMORELIN-10MG match the procurement request.
• Review both reports as complete records, including the lot identifiers, methods, dates, specifications and results.
• Treat numerical results as data for the reported sample rather than blanket product guarantees.
• Apply your laboratory’s own supplier-qualification, acceptance, storage and handling procedures.

Tesamorelin 10mg FAQs

What is listed on this Tesamorelin 10mg page?

This page lists Tesamorelin with a stated quantity of 10mg, supplied in a lyophilized vial under SKU PC-TESAMORELIN-10MG for qualified laboratory research.

Which documents are available for this listing?

The page links to a two-page UPLC/MS report and a separate endotoxin report. Review each complete document and confirm its compound identity, lot, method, dates, specification fields and results.

What does the Tesamorelin UPLC/MS report show?

For lot PCCL-4867057-P, the report identifies Tesamorelin and records 10.13mg measured quantity and 99.23% purity. These are results for the submitted sample and do not establish sterility, safety or suitability.

What document limitations should be noted?

The endotoxin report prints no acceptance specification, and both reports show an analysis date earlier than the received date. Buyers should evaluate those limitations under their own laboratory procedures rather than treating the documents as pass-style labels.

Is Tesamorelin 10mg intended for human use?

No. This product is supplied only for qualified laboratory research and is not for human or veterinary administration. Purity Collective does not provide clinical, therapeutic, dosing or administration guidance.

Research-use notice

For qualified laboratory research only. Not for human or veterinary administration. This listing is not presented as a medicine or treatment.